Edap Tms S.A. (NASDAQ:EDAP) Short Interest Update

Edap Tms S.A. (NASDAQ:EDAP) saw a significant growth in short interest in January. As of January 31st, there was short interest totalling 31,700 shares, a growth of 74.2% from the January 15th total of 18,200 shares. Based on an average trading volume of 108,700 shares, the short-interest ratio is presently 0.3 days.

Edap Tms Price Performance

NASDAQ:EDAP traded up $0.23 during midday trading on Friday, hitting $2.86. The company had a trading volume of 90,269 shares, compared to its average volume of 38,485. The stock’s fifty day moving average price is $2.30 and its 200-day moving average price is $2.84. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. Edap Tms has a 52-week low of $2.00 and a 52-week high of $8.50. The company has a market capitalization of $106.11 million, a PE ratio of -4.40 and a beta of 0.36.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on shares of Edap Tms in a research report on Saturday, February 8th. They issued a “hold” rating for the company.

Institutional Trading of Edap Tms

Several institutional investors have recently added to or reduced their stakes in EDAP. Redhawk Wealth Advisors Inc. purchased a new stake in Edap Tms during the third quarter valued at about $36,000. BNP Paribas Financial Markets boosted its position in Edap Tms by 23.7% during the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after buying an additional 4,400 shares during the period. Parkman Healthcare Partners LLC purchased a new stake in Edap Tms during the third quarter valued at about $395,000. Orion Capital Management LLC boosted its position in Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after buying an additional 6,600 shares during the period. Finally, Illumine Investment Management LLC purchased a new stake in Edap Tms during the fourth quarter valued at about $50,000. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.